Skip to content

Clinical trials

Phase 3 Non-alcoholic Fatty Liver Disease trials in Spain

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Non-alcoholic Fatty Liver Disease Phase: Phase 3 Country / region: Spain Clear all

16 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20081
20151
20161
20174
20191
20201
20212
20244
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Terminated7
Recruiting4
Active, not recruiting3
Completed2

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
89bio, Inc.2
Gilead Sciences2
Intercept Pharmaceuticals2
Akero Therapeutics, Inc1
Boehringer Ingelheim1
Eli Lilly and Company1
Genfit1
GlaxoSmithKline1
Inventiva Pharma1
Madrigal Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Non-alcoholic Fatty Liver Disease16
Fibrosis4
Liver Diseases4
Fatty Liver3
Digestive System Diseases2
Metabolic Diseases2
Acquired Immunodeficiency Syndrome1
HIV Infections1
Hepatitis B1
Hepatitis C1

Trials

Showing 1 to 16 of 16. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.